HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of the delta-opioid receptor found in SH-SY5Y neuroblastoma cells.

Abstract
The delta-opioid receptor found in SH-SY5Y cells was characterized in terms of binding profile and ability to mediate the inhibition of forskolin-stimulated cAMP accumulation. Both DPDPE ([D-Pen2,D-Pen5]enkephalin) and deltorphin II, compounds reported to be selective for the delta 1- and delta 2-opioid receptor respectively, were potent agonists in these cells. Binding studies indicated that naltrindole benzofuran (NTB) had significantly higher affinity than 7-benzylidenenaltrexone (BNTX); however, both compounds have high affinity for the delta-opioid receptor found in SH-SY5Y cells. Naltrindole benzofuran was found to be a potent antagonist, with an IC50 of less than 1 nM, while 7-benzylidene naltrexone was found to be a relatively weak antagonist, requiring greater than 100 nM to inhibit 50% of agonist activity. Binding to intact SH-SY5Y cells was compared to binding to cell membranes and guinea-pig brain membranes. In each case, binding affinities were very similar. These studies suggest that the receptor found in SH-SY5Y cells could probably be classified as a delta 2-opioid receptor. However, the very similar binding characteristics of SH-SY5Y cells and guinea-pig brain membranes call into question the ability to label delta 1-opioid receptors.
AuthorsL Toll, W E Polgar, J S Auh
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 323 Issue 2-3 Pg. 261-7 (Apr 04 1997) ISSN: 0014-2999 [Print] Netherlands
PMID9128848 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Receptors, sigma
  • Cyclic AMP
Topics
  • Animals
  • Binding, Competitive
  • Brain (metabolism)
  • Cyclic AMP (metabolism)
  • Guinea Pigs
  • Humans
  • Membranes (metabolism)
  • Neuroblastoma (metabolism, pathology)
  • Receptors, sigma (drug effects, metabolism)
  • Tumor Cells, Cultured (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: